Atrial fibrillation represents a common and challenging arrhythmia. A rational approach to
management of the individual case depends on careful assessment of the temporal pattern …

Blaauw Y, Crijns HJGM (University Hospital Maastricht, Maastricht, The Netherlands). Atrial
fibrillation: insights from clinical trials and novel treatment options (Review). J Intern Med …

Atrial fibrillation (AF) is a growing clinical problem associated with increased morbidity and
mortality. Currently available antiarrhythmic drugs (AADs), although highly effective in acute …

Hybrid Therapy for Atrial Fibrillation. Nonpharmacologic techniques are being increasingly
applied to the treatment of atrial fibrillation (AF). None of these techniques (other than maze …

Despite the major new insights into our knowledge of the mechanisms underlying initiation
and perpetuation of atrial fibrillation (AF) gained in the last decade, the treatment of this …

Controlling the ventricular rate during both paroxysmal and persistent atrial fibrillation (AF),
initially with digitalis preparations and subsequently with-blockers and calcium channel …

Atrial fibrillation (AF) is one of the main cardiac arrhythmias associated with higher risk of
cardiovascular morbidity and mortality. AF can cause adverse symptoms and reduced …

Atrial fibrillation (AF) has been the subject of considerable attention and intensive clinical
research in recent years. Current opinion among physicians on the management of AF …

Sinus node disease (SND), a common indication to implant a pacemaker, is frequently
associated with atrial fibrillation (AF), either at implantation (paroxysmal AF) or during follow …

Although atrial fibrillation is the most common sustained arrhythmia that requires medical
attention, it remains a challenge to treat. Nevertheless, considerable progress has been …